Back to Browse Journals » Infection and Drug Resistance » Volume 5

Clinical update on linezolid in the treatment of Gram-positive bacterial infections

Authors Ager S, Gould K

Published Date June 2012 Volume 2012:5 Pages 87—102

DOI http://dx.doi.org/10.2147/IDR.S25890

Received 13 April 2012, Accepted 20 April 2012, Published 25 June 2012

Sally Ager, Kate Gould

Department of Microbiology, Newcastle upon Tyne Hospitals Trust, Freeman Hospital, High Heaton, Newcastle upon Tyne, UK


Abstract: Gram-positive pathogens are a significant cause of morbidity and mortality in both community and health care settings. Glycopeptides have traditionally been the antibiotics of choice for multiresistant Gram-positive pathogens but there are problems with their use, including the emergence of glycopeptide-resistant strains, tissue penetration, and achieving and monitoring adequate serum levels. Newer antibiotics such as linezolid, a synthetic oxazolidinone, are available for the treatment of resistant Gram-positive bacteria. Linezolid is active against a wide range of Gram-positive bacteria and has been generally available for the treatment of Gram-positive infections since 2000. There are potential problems with linezolid use, including its bacteriostatic action and the relatively high incidence of reported adverse effects, particularly with long-term use. Long-term use may also be complicated by the development of resistance. However, linezolid has been shown to be clinically useful in the treatment of several serious infections where traditionally bacteriocidal agents have been required and many of its adverse effects are reversible on cessation. It has also been shown to be a cost-effective treatment option in several studies, with its high oral bioavailability allowing an early change from intravenous to oral formulations with consequent earlier patient discharge and lower inpatient costs.

Keywords: linezolid, oxazolidinone, multi-resistant, gram-positive, MRSA, VRE, cost-benefit

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Wearing-off in Parkinson’s disease: neuropsychological differences between on and off periods

Caillava-Santos F, Margis R, Rieder CR

Neuropsychiatric Disease and Treatment 2015, 11:1175-1180

Published Date: 13 May 2015

pH-sensitive poly(lactide-co-glycolide) nanoparticle composite microcapsules for oral delivery of insulin

Sun S, Liang N, Yamamoto H, Kawashima Y, Cui F, Yan P

International Journal of Nanomedicine 2015, 10:3489-3498

Published Date: 11 May 2015

Letter to the editor

Ralla B, Holtmann C, Geerling G

Clinical Ophthalmology 2013, 7:243-246

Published Date: 5 February 2013

Mannan-modified Ad5-PTEN treatment combined with docetaxel improves the therapeutic effect in H22 tumor-bearing mice

Liu Z, Li J, Li J, Huang J, Ke F, Qi Q, Jiang X, Zhong Z

International Journal of Nanomedicine 2012, 7:5039-5049

Published Date: 17 September 2012

Functionalization of single-walled carbon nanotubes and their binding to cancer cells

Madani SY, Tan A, Dwek M, Seifalian AM

International Journal of Nanomedicine 2012, 7:905-914

Published Date: 22 February 2012

The Automated Breast Volume Scanner (ABVS): initial experiences in lesion detection compared with conventional handheld B-mode ultrasound: a pilot study of 50 cases

Wojcinski S, Farrokh A, Hille U, Wiskirchen J, Gyapong S, Soliman AA, Degenhardt F, Hillemanns P

International Journal of Women's Health 2011, 3:337-346

Published Date: 11 October 2011

Microemulsion-based novel transdermal delivery system of tetramethylpyrazine: preparation and evaluation in vitro and in vivo

Zhao JH, Ji L, Wang H, Chen ZQ, Zhang YT, Liu Y, Feng NP

International Journal of Nanomedicine 2011, 6:1611-1619

Published Date: 9 August 2011

Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

Rocío Herrero-Vanrell, Jose Augusto Cardillo, Baruch D Kuppermann

Clinical Ophthalmology 2011, 5:139-146

Published Date: 1 February 2011

Autoantibodies, human Fcγ receptors, and autoimmunity

Margherita Sisto, Sabrina Lisi, Simona D’Amore, et al

Journal of Receptor, Ligand and Channel Research 2009, 2:45-57

Published Date: 4 November 2009